Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bruschi, GCM; de Souza, CC; Fagundes, MRVK; Dani, MAC; Goldman, MHS; Morris, NR; Liu, L; Goldman, GH
   Sensitivity to camptothecin in Aspergillus nidulans identifies a novel gene, scaA(+), related to the cellular DNA damage response
   MOLECULAR GENETICS AND GENOMICS
   
   G.C.M. Bruschi et al., "Sensitivity to camptothecin in Aspergillus nidulans identifies a novel gene, scaA(+), related to the cellular DNA damage response", MOL GENET G, 265(2), 2001, pp. 264-275
2. Streltsov, S; Sukhanova, A; Mikheikin, A; Grokhovsky, S; Zhuze, A; Kudelina, I; Mochalov, K; Oleinikov, V; Jardillier, JC; Nabiev, I
   Structural basis of Topotecan-DNA recognition probed by flow linear dichroism, circular dichroism, and Raman spectroscopy
   JOURNAL OF PHYSICAL CHEMISTRY B
   
   S. Streltsov et al., "Structural basis of Topotecan-DNA recognition probed by flow linear dichroism, circular dichroism, and Raman spectroscopy", J PHYS CH B, 105(39), 2001, pp. 9643-9652
3. Gunzburg, WH; Salmons, B
   Novel clinical strategies for the treatment of pancreatic carcinoma
   TRENDS IN MOLECULAR MEDICINE
   
   W.H. Gunzburg e B. Salmons, "Novel clinical strategies for the treatment of pancreatic carcinoma", TRENDS MO M, 7(1), 2001, pp. 30-37
4. Czuwara-Ladykowska, J; Makiela, B; Smith, EA; Trojanowska, M; Rudnicka, L
   The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis
   ARTHRITIS RESEARCH
   
   J. Czuwara-Ladykowska et al., "The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis", ARTHRITIS R, 3(5), 2001, pp. 311-318
5. Tsai, TH
   Analytical approaches for traditional Chinese medicines exhibiting antineoplastic activity
   JOURNAL OF CHROMATOGRAPHY B
   
   T.H. Tsai, "Analytical approaches for traditional Chinese medicines exhibiting antineoplastic activity", J CHROMAT B, 764(1-2), 2001, pp. 27-48
6. Oguma, T
   Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods
   JOURNAL OF CHROMATOGRAPHY B
   
   T. Oguma, "Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods", J CHROMAT B, 764(1-2), 2001, pp. 49-58
7. Palumbo, M; Sissi, C; Gatto, B; Moro, S; Zagotto, G
   Quantitation of camptothecin and related compounds
   JOURNAL OF CHROMATOGRAPHY B
   
   M. Palumbo et al., "Quantitation of camptothecin and related compounds", J CHROMAT B, 764(1-2), 2001, pp. 121-140
8. Zufia, L; Aldaz, A; Giraldez, J
   Separation methods for camptothecin and related compounds
   JOURNAL OF CHROMATOGRAPHY B
   
   L. Zufia et al., "Separation methods for camptothecin and related compounds", J CHROMAT B, 764(1-2), 2001, pp. 141-159
9. Schoemaker, NE; Frigerio, E; Fraier, D; Schellens, JHM; Rosing, H; Jansen, S; Beijnen, JH
   High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
   JOURNAL OF CHROMATOGRAPHY B
   
   N.E. Schoemaker et al., "High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma", J CHROMAT B, 763(1-2), 2001, pp. 173-183
10. Smith, JA; Cortes, J; Newman, RA; Madden, TL
    Development of a simplified, sensitive high-performance liquid chromatographic method using fluorescence detection to determine the concentration of UCN-01 in human plasma
    JOURNAL OF CHROMATOGRAPHY B
    
    J.A. Smith et al., "Development of a simplified, sensitive high-performance liquid chromatographic method using fluorescence detection to determine the concentration of UCN-01 in human plasma", J CHROMAT B, 760(2), 2001, pp. 247-253
11. Smith, JA; Hausheer, F; Newman, RA; Madden, TL
    Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecinderivative, in human plasma and urine
    JOURNAL OF CHROMATOGRAPHY B
    
    J.A. Smith et al., "Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecinderivative, in human plasma and urine", J CHROMAT B, 759(1), 2001, pp. 117-124
12. Balestrieri, E; Zanier, R; Degrassi, F
    Molecular characterisation of camptothecin-induced mutations at the hprt locus in Chinese hamster cells
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    E. Balestrieri et al., "Molecular characterisation of camptothecin-induced mutations at the hprt locus in Chinese hamster cells", MUT RES-F M, 476(1-2), 2001, pp. 63-69
13. Olsson, G; Belyaev, IY; Helleday, T; Harms-Ringdahl, M
    ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cellsbut does not interact with intrachromosomal recombination
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    G. Olsson et al., "ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cellsbut does not interact with intrachromosomal recombination", MUT RES-GTE, 493(1-2), 2001, pp. 55-66
14. Jung, LL; Zamboni, WC
    Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    DRUG RESISTANCE UPDATES
    
    L.L. Jung e W.C. Zamboni, "Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?", DRUG RESIST, 4(3), 2001, pp. 152-167
15. Pouliot, JJ; Robertson, CA; Nash, HA
    Pathways for repair of topoisomerase I covalent complexes in Saccharomycescerevisiae
    GENES TO CELLS
    
    J.J. Pouliot et al., "Pathways for repair of topoisomerase I covalent complexes in Saccharomycescerevisiae", GENES CELLS, 6(8), 2001, pp. 677-687
16. Bugreev, DV; Vasyutina, EL; Ryabinin, VA; Sinyakov, AN; Buneva, VN; Nevinsky, GA
    Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: Derivatives of oligo-1,3-thiazolecarboxamides
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    
    D.V. Bugreev et al., "Inhibition of human DNA topoisomerase I by new DNA minor groove ligands: Derivatives of oligo-1,3-thiazolecarboxamides", ANTISENSE N, 11(3), 2001, pp. 137-147
17. Abraham, EH; Shrivastav, B; Salikhova, AY; Sterling, KM; Johnston, N; Guidotti, G; Scala, S; Litman, T; Chan, KC; Arceci, RJ; Steiglitz, K; Herscher, L; Okunieff, P
    Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes
    BLOOD CELLS MOLECULES AND DISEASES
    
    E.H. Abraham et al., "Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes", BL CELL M D, 27(1), 2001, pp. 181-200
18. Mathijssen, RHJ; van Alphen, RJ; Verweij, J; Loos, WJ; Nooter, K; Stoter, G; Sparreboom, A
    Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)
    CLINICAL CANCER RESEARCH
    
    R.H.J. Mathijssen et al., "Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)", CLIN CANC R, 7(8), 2001, pp. 2182-2194
19. Rieber, MS; Zangemeister-Wittke, U; Rieber, M
    P53-independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide
    CLINICAL CANCER RESEARCH
    
    M.S. Rieber et al., "P53-independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide", CLIN CANC R, 7(5), 2001, pp. 1446-1451
20. Takimoto, CH
    Why drugs fail: Of mice and men revisited
    CLINICAL CANCER RESEARCH
    
    C.H. Takimoto, "Why drugs fail: Of mice and men revisited", CLIN CANC R, 7(2), 2001, pp. 229-230
21. Blaney, S; Berg, SL; Pratt, C; Weitman, S; Sullivan, J; Luchtman-Jones, L; Bernstein, M
    A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study
    CLINICAL CANCER RESEARCH
    
    S. Blaney et al., "A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study", CLIN CANC R, 7(1), 2001, pp. 32-37
22. Jagasia, MH; Langer, CJ; Johnson, DH; Yunus, F; Rodgers, JS; Schlabach, LL; Cohen, AG; Shyr, Y; Carbone, DP; DeVore, RF
    Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study
    CLINICAL CANCER RESEARCH
    
    M.H. Jagasia et al., "Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study", CLIN CANC R, 7(1), 2001, pp. 68-73
23. Li, ML; Horn, L; Firby, PS; Moore, MJ
    Pharmacological determinants of 9-aminocamptothecin cytotoxicity
    CLINICAL CANCER RESEARCH
    
    M.L. Li et al., "Pharmacological determinants of 9-aminocamptothecin cytotoxicity", CLIN CANC R, 7(1), 2001, pp. 168-174
24. Takebayashi, Y; Goldwasser, F; Urasaki, Y; Kohlhagen, G; Pommier, Y
    Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression
    CLINICAL CANCER RESEARCH
    
    Y. Takebayashi et al., "Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression", CLIN CANC R, 7(1), 2001, pp. 185-191
25. Kanzawa, F; Koizumi, F; Koh, Y; Nakamura, T; Tatsumi, Y; Fukumoto, H; Saijo, N; Yoshioka, T; Nishio, K
    In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction
    CLINICAL CANCER RESEARCH
    
    F. Kanzawa et al., "In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction", CLIN CANC R, 7(1), 2001, pp. 202-209
26. Scaldaferro, S; Tinelli, S; Borgnetto, ME; Azzini, A; Capranico, G
    Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I
    CHEMISTRY & BIOLOGY
    
    S. Scaldaferro et al., "Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I", CHEM BIOL, 8(9), 2001, pp. 871-881
27. Thengane, SR; Kulkarni, DK; Shrikhande, VA; Krishnamurthy, KV
    Effect of thidiazuron on adventitious shoot regeneration from seedling explants of Nothapodytes foetida
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-PLANT
    
    S.R. Thengane et al., "Effect of thidiazuron on adventitious shoot regeneration from seedling explants of Nothapodytes foetida", IN VITRO-PL, 37(2), 2001, pp. 206-210
28. Senter, PD; Beam, KS; Mixan, B; Wahl, AF
    Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug
    BIOCONJUGATE CHEMISTRY
    
    P.D. Senter et al., "Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug", BIOCONJ CHE, 12(6), 2001, pp. 1074-1080
29. Arimondo, PB; Bailly, C; Boutorine, AS; Moreau, P; Prudhomme, M; Sun, JS; Garestier, T; Helene, C
    Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site
    BIOCONJUGATE CHEMISTRY
    
    P.B. Arimondo et al., "Triple helix-forming oligonucleotides conjugated to indolocarbazole poisons direct topoisomerase I-mediated DNA cleavage to a specific site", BIOCONJ CHE, 12(4), 2001, pp. 501-509
30. Takagi, T; Saotome, T
    Chemotherapy with irinotecan (CPT-11), a topoisomerase-I inhibitor, for refractory and relapsed non-Hodgkin's lymphoma
    LEUKEMIA & LYMPHOMA
    
    T. Takagi e T. Saotome, "Chemotherapy with irinotecan (CPT-11), a topoisomerase-I inhibitor, for refractory and relapsed non-Hodgkin's lymphoma", LEUK LYMPH, 42(4), 2001, pp. 577-586
31. Platzer, P; Thalhammer, T; Reznicek, G; Hamilton, G; Zhang, RW; Jager, W
    Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    P. Platzer et al., "Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver", INT J ONCOL, 19(6), 2001, pp. 1287-1293
32. Okamoto, R; Takano, H; Sekikawa, T; Tanaka, T; Toyada, M; Ukon, K; Tanimoto, K; Kumazaki, T; Nishiyama, M
    Unique action determinants of double acting topoisomerase inhibitor, TAS-103
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    R. Okamoto et al., "Unique action determinants of double acting topoisomerase inhibitor, TAS-103", INT J ONCOL, 19(5), 2001, pp. 921-927
33. Cosentini, E; Haberl, I; Pertschy, P; Teleky, B; Mallinger, R; Baumgartner, G; Wenzl, E; Hamilton, G
    The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    E. Cosentini et al., "The differentiation inducers phenylacetate and phenylbutyrate modulate camptothecin sensitivity in colon carcinoma cells in vitro by intracellular acidification", INT J ONCOL, 19(5), 2001, pp. 1069-1074
34. Smolewski, P; Grabarek, J; Phelps, DJ; Darzynkiewicz, Z
    Stathmo-apoptosis: Arresting apoptosis by fluorochrome-labeled inhibitor of caspases
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    P. Smolewski et al., "Stathmo-apoptosis: Arresting apoptosis by fluorochrome-labeled inhibitor of caspases", INT J ONCOL, 19(4), 2001, pp. 657-663
35. Redkar, AA; Meadows, GG; Daoud, SS
    UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    A.A. Redkar et al., "UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice", INT J ONCOL, 19(1), 2001, pp. 193-199
36. Zou, YY; Wu, QP; Tansey, W; Chow, D; Hung, MC; Vej, CC; Wallace, S; Li, C
    Effectiveness of water soluble poly(L-glutamic acid)camptothecin conjugateagainst resistant human lung cancer xenografted in nude mice
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    Y.Y. Zou et al., "Effectiveness of water soluble poly(L-glutamic acid)camptothecin conjugateagainst resistant human lung cancer xenografted in nude mice", INT J ONCOL, 18(2), 2001, pp. 331-336
37. Lin, CF; Hsieh, PC; Lu, WD; Chiu, HF; Wu, MJ
    A series of enediynes as novel inhibitors of topoisomerase I
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    C.F. Lin et al., "A series of enediynes as novel inhibitors of topoisomerase I", BIO MED CH, 9(7), 2001, pp. 1707-1711
38. Aubert, Y; Perrouault, L; Helene, C; Giovannangeli, C; Asseline, U
    Synthesis and properties of triple helix-forming oligodeoxyribonucleotidescontaining 7-chloro-7-deaza-2 '-deoxyguanosine
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    Y. Aubert et al., "Synthesis and properties of triple helix-forming oligodeoxyribonucleotidescontaining 7-chloro-7-deaza-2 '-deoxyguanosine", BIO MED CH, 9(6), 2001, pp. 1617-1624
39. Voldoire, A; Sancelme, M; Prudhomme, M; Colson, P; Houssier, C; Bailly, C; Leonce, S; Lambel, S
    Rebeccamycin analogues from indolo[2,3-c] carbazole
    BIOORGANIC & MEDICINAL CHEMISTRY
    
    A. Voldoire et al., "Rebeccamycin analogues from indolo[2,3-c] carbazole", BIO MED CH, 9(2), 2001, pp. 357-365
40. Distefano, M; Ferlini, C; De Vincenzo, R; Gaggini, C; Mancuso, S; Scambia, G
    Antagonistic effect of the combination gemcitabine/topotecan in ovarian cancer cells
    ONCOLOGY RESEARCH
    
    M. Distefano et al., "Antagonistic effect of the combination gemcitabine/topotecan in ovarian cancer cells", ONCOL RES, 12(9-10), 2001, pp. 355-359
41. Pessina, A; Raimondi, A; Cerri, A; Piccirillo, M; Neri, MG; Croera, C; Foti, P; Berti, E
    High sensitivity of human epidermal keratinocytes (HaCaT) to topoisomeraseinhibitors
    CELL PROLIFERATION
    
    A. Pessina et al., "High sensitivity of human epidermal keratinocytes (HaCaT) to topoisomeraseinhibitors", CELL PROLIF, 34(4), 2001, pp. 243-252
42. Orlandi, L; Colella, G; Bearzatto, A; Abolafio, G; Manzotti, C; Daidone, MG; Zaffaroni, N
    Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cellcycle progression and induction of apoptosis
    EUROPEAN JOURNAL OF CANCER
    
    L. Orlandi et al., "Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cellcycle progression and induction of apoptosis", EUR J CANC, 37(5), 2001, pp. 649-659
43. Boucard, M; Pinguet, F; Poujol, S; Romieu, G; Cupissol, D; Astre, C; Culine, S; Bressolle, F
    Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Boucard et al., "Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer", EUR J CANC, 37(18), 2001, pp. 2357-2364
44. Desjardins, JP; Abbott, EA; Emerson, DL; Tomkinson, BE; Leray, JD; Brown, EN; Hamilton, M; Dihel, L; Ptaszynski, M; Bendele, RA; Richardson, FC
    Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice
    ANTI-CANCER DRUGS
    
    J.P. Desjardins et al., "Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice", ANTI-CANC D, 12(3), 2001, pp. 235-245
45. Kehrer, DFS; Soepenberg, O; Loos, WJ; Verweij, J; Sparreboom, A
    Modulation of camptothecin analogs in the treatment of cancer: a review
    ANTI-CANCER DRUGS
    
    D.F.S. Kehrer et al., "Modulation of camptothecin analogs in the treatment of cancer: a review", ANTI-CANC D, 12(2), 2001, pp. 89-105
46. Demarquay, D; Huchet, M; Coulomb, H; Lesueur-Ginot, L; Lavergne, O; Kasprzyk, PG; Bailly, C; Camara, J; Bigg, DCH
    The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison
    ANTI-CANCER DRUGS
    
    D. Demarquay et al., "The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison", ANTI-CANC D, 12(1), 2001, pp. 9-19
47. Niitsu, N; Iijima, K; Chizuka, A
    Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study
    ANNALS OF HEMATOLOGY
    
    N. Niitsu et al., "Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study", ANN HEMATOL, 80(7), 2001, pp. 411-416
48. Bowman, WR; Bridge, CF; Cloonan, MO; Leach, DC
    Synthesis of heteroarenes via radical cyclisation onto nitriles
    SYNLETT
    
    W.R. Bowman et al., "Synthesis of heteroarenes via radical cyclisation onto nitriles", SYNLETT, (6), 2001, pp. 765-768
49. Alberts, SR; Erlichman, C; Sloan, J; Okuno, SH; Burch, PA; Rubin, J; Pitot, HC; Goldberg, RM; Adjei, AA; Atherton, PJ; Kaufmann, SH
    Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
    ANNALS OF ONCOLOGY
    
    S.R. Alberts et al., "Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks", ANN ONCOL, 12(5), 2001, pp. 627-631
50. Huisman, C; Postmus, PE; Giaccone, G; Smit, EF
    A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients
    ANNALS OF ONCOLOGY
    
    C. Huisman et al., "A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients", ANN ONCOL, 12(11), 2001, pp. 1567-1573
51. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
    Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
    ANNALS OF ONCOLOGY
    
    M.L. Rothenberg et al., "Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks", ANN ONCOL, 12(11), 2001, pp. 1631-1641
52. Saita, T; Fujito, H; Mori, M
    Determination of topotecan by ELISA
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    T. Saita et al., "Determination of topotecan by ELISA", BIOL PHAR B, 24(4), 2001, pp. 321-326
53. Oguma, T; Yamada, M; Konno, T; Inukai, K; Nakaoka, M
    High-performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (Exatecan), in mouse plasma
    BIOLOGICAL & PHARMACEUTICAL BULLETIN
    
    T. Oguma et al., "High-performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (Exatecan), in mouse plasma", BIOL PHAR B, 24(2), 2001, pp. 176-180
54. Popanda, O; Flohr, C; Dai, JC; Hunzicker, A; Thielmann, HW
    A mutation in subunit B of the DNA polymerase alpha-primase complex from Novikoff hepatoma cells concomitant with a conformational change and abnormal catalytic properties of the DNA polymerase alpha-primase complex
    MOLECULAR CARCINOGENESIS
    
    O. Popanda et al., "A mutation in subunit B of the DNA polymerase alpha-primase complex from Novikoff hepatoma cells concomitant with a conformational change and abnormal catalytic properties of the DNA polymerase alpha-primase complex", MOL CARCINO, 31(4), 2001, pp. 171-183
55. Rich, TA; Kirichenko, AV
    Camptothecin schedule and timing of administration with irradiation
    ONCOLOGY-NEW YORK
    
    T.A. Rich e A.V. Kirichenko, "Camptothecin schedule and timing of administration with irradiation", ONCOLOGY-NY, 15(3), 2001, pp. 37-41
56. Vanhoefer, U; Harstrick, A; Achterrath, W; Cao, SS; Seeber, S; Rustum, YM
    Irinotecan in the treatment of colorectal cancer: Clinical overview
    JOURNAL OF CLINICAL ONCOLOGY
    
    U. Vanhoefer et al., "Irinotecan in the treatment of colorectal cancer: Clinical overview", J CL ONCOL, 19(5), 2001, pp. 1501-1518
57. Fisher, BJ; Scott, C; Macdonald, DR; Coughlin, C; Curran, WJ
    Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507
    JOURNAL OF CLINICAL ONCOLOGY
    
    B.J. Fisher et al., "Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group Trial 9507", J CL ONCOL, 19(4), 2001, pp. 1111-1117
58. Falcone, A; Di Paolo, A; Masi, G; Allegrini, G; Danesi, R; Lencioni, M; Pfanner, E; Comis, S; Del Tacca, M; Conte, P
    Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Falcone et al., "Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients", J CL ONCOL, 19(15), 2001, pp. 3456-3462
59. Arimori, K; Kuroki, N; Kumamoto, A; Tanoue, N; Nakano, M; Kumazawa, E; Tohgo, A; Kikuchi, M
    Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents
    PHARMACEUTICAL RESEARCH
    
    K. Arimori et al., "Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents", PHARM RES, 18(6), 2001, pp. 814-822
60. Saito, K; Sudo, H; Yamazaki, M; Koseki-Nakamura, M; Kitajima, M; Takayama, H; Aimi, N
    Feasible production of camptothecin by hairy root culture of Ophiorrhiza pumila
    PLANT CELL REPORTS
    
    K. Saito et al., "Feasible production of camptothecin by hairy root culture of Ophiorrhiza pumila", PL CELL REP, 20(3), 2001, pp. 267-271
61. Nakazawa, N; Tagami, K; Iimori, H; Sano, L; Ishikawa, T; Nagao, Y
    Copper(I) iodide-promoted hydroxylation onto the lithium or potassium enolate of lactones and lactams
    HETEROCYCLES
    
    N. Nakazawa et al., "Copper(I) iodide-promoted hydroxylation onto the lithium or potassium enolate of lactones and lactams", HETEROCYCLE, 55(11), 2001, pp. 2157-2170
62. Biswas, A; Dey, J
    Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study
    INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY
    
    A. Biswas e J. Dey, "Ground and excited-state ionization behavior of 9-aminocamptothecin: An absorption and fluorescence spectral study", I J CHEM A, 40(11), 2001, pp. 1143-1148
63. Shigeoka, Y; Itoh, K; Igarashi, T; Ishizawa, K; Saeki, T; Fujii, H; Minami, H; Imoto, S; Sasaki, Y
    Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    Y. Shigeoka et al., "Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxel-containing regimens", JPN J CLIN, 31(8), 2001, pp. 370-374
64. Li, TK; Liu, LF
    Tumor cell death induced by topoisomerase-targeting drugs
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    
    T.K. Li e L.F. Liu, "Tumor cell death induced by topoisomerase-targeting drugs", ANN R PHARM, 41, 2001, pp. 53-77
65. Canalle, R; Burim, RV; Lopes, JLC; Takahashi, CS
    Assessment of the cytotoxic and clastogenic activities of the sesquiterpene lactone lychnopholide in mammalian cells in vitro and in vivo
    CANCER DETECTION AND PREVENTION
    
    R. Canalle et al., "Assessment of the cytotoxic and clastogenic activities of the sesquiterpene lactone lychnopholide in mammalian cells in vitro and in vivo", CANCER DET, 25(1), 2001, pp. 93-101
66. Chastagner, P; Kozin, SV; Taghian, A
    Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    P. Chastagner et al., "Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice", INT J RAD O, 50(3), 2001, pp. 777-782
67. Bahadori, HR; Green, MR; Catapano, CV
    Synergistic interaction between topotecan and microtubule-interfering agents
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    H.R. Bahadori et al., "Synergistic interaction between topotecan and microtubule-interfering agents", CANC CHEMOT, 48(3), 2001, pp. 188-196
68. Thomas, RR; Dahut, W; Harold, N; Grem, JL; Monahan, BP; Liang, M; Band, RA; Cottrell, J; Llorens, V; Smith, JA; Corse, W; Arbuck, SG; Wright, J; Chen, AP; Hamilton, JM; Allegra, CJ; Takimoto, CH
    A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    R.R. Thomas et al., "A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients", CANC CHEMOT, 48(3), 2001, pp. 215-222
69. Sloan, JA; Atherton, P; Reid, J; Pilot, HC; Erlichman, C; Schaaf, L
    Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    J.A. Sloan et al., "Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide", CANC CHEMOT, 48(3), 2001, pp. 241-249
70. Takeda, K; Negoro, S; Takifuji, N; Nitta, T; Yoshimura, N; Terakawa, K; Fukuoka, M
    Dose escalation study of irinotecan combined with carboplatin for advancednon-small-cell lung cancer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    K. Takeda et al., "Dose escalation study of irinotecan combined with carboplatin for advancednon-small-cell lung cancer", CANC CHEMOT, 48(2), 2001, pp. 104-108
71. Keir, ST; Hausheer, F; Lawless, AA; Bigner, DD; Friedman, HS
    Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    S.T. Keir et al., "Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice", CANC CHEMOT, 48(1), 2001, pp. 83-87
72. Ling, YH; Donato, NJ; Perez-Soler, R
    Sensitivity to topoisomerase I inhibitors and cisplatin is associated withepidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    Y.H. Ling et al., "Sensitivity to topoisomerase I inhibitors and cisplatin is associated withepidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines", CANC CHEMOT, 47(6), 2001, pp. 473-480
73. Koshkina, NV; Knight, V; Gilbert, BE; Golunski, E; Roberts, L; Waldrep, JC
    Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    N.V. Koshkina et al., "Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies", CANC CHEMOT, 47(5), 2001, pp. 451-456
74. Cholody, WM; Kosakowska-Cholody, T; Michejda, CJ
    Bisimidazoacridones induce a potent cytostatic effect in colon tumor cellsthat sensitizes them to killing by UCN-01
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    W.M. Cholody et al., "Bisimidazoacridones induce a potent cytostatic effect in colon tumor cellsthat sensitizes them to killing by UCN-01", CANC CHEMOT, 47(3), 2001, pp. 241-249
75. Soe, K; Dianov, G; Nasheuer, HP; Bohr, VA; Grosse, F; Stevnsner, T
    A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro
    NUCLEIC ACIDS RESEARCH
    
    K. Soe et al., "A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro", NUCL ACID R, 29(15), 2001, pp. 3195-3203
76. Kobayashi, K; Ceryak, S; Matsuzaki, Y; Kudoh, S; Bouscarel, B
    Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    
    K. Kobayashi et al., "Effect of bile acids on the uptake of irinotecan and its active metabolite, SN-38, by intestinal cells", BBA-GEN SUB, 1525(1-2), 2001, pp. 125-129
77. Mitani, N; Murakami, K; Yamaura, T; Ikeda, T; Saiki, I
    Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma
    CANCER LETTERS
    
    N. Mitani et al., "Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma", CANCER LETT, 165(1), 2001, pp. 35-42
78. Gil-Delgado, MA; Guinet, F; Castaing, D; Adam, R; Coeffic, D; Durrani, AKS; Bismuth, H; Khayat, D
    Prospective phase II trial of irinotecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    M.A. Gil-Delgado et al., "Prospective phase II trial of irinotecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer", AM J CL ONC, 24(1), 2001, pp. 101-105
79. Burim, RV; Canalle, R; Lopes, JLC; Vichnewski, W; Takahashi, CS
    Genotoxic action of the sesquiterpene lactone centratherin on mammalian cells in vitro and in vivo
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    
    R.V. Burim et al., "Genotoxic action of the sesquiterpene lactone centratherin on mammalian cells in vitro and in vivo", TER CAR MUT, 21(6), 2001, pp. 383-393
80. Topcu, Z
    DNA topoisomerases as targets for anticancer drugs
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    
    Z. Topcu, "DNA topoisomerases as targets for anticancer drugs", J CLIN PH T, 26(6), 2001, pp. 405-416
81. Hanioka, N; Jinno, H; Nishimura, T; Ando, M; Ozawa, S; Sawada, J
    High-performance liquid chromatographic assay for glucuronidation activityof 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes
    BIOMEDICAL CHROMATOGRAPHY
    
    N. Hanioka et al., "High-performance liquid chromatographic assay for glucuronidation activityof 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes", BIOMED CHRO, 15(5), 2001, pp. 328-333
82. Oguma, T; Konno, T; Inaba, A; Nakaoka, M
    Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry
    BIOMEDICAL CHROMATOGRAPHY
    
    T. Oguma et al., "Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry", BIOMED CHRO, 15(2), 2001, pp. 108-115
83. Zhou, JJ; Liu, J; Xu, B
    Relationship between lactone ring forms of HCPT and their antitumor activities
    ACTA PHARMACOLOGICA SINICA
    
    J.J. Zhou et al., "Relationship between lactone ring forms of HCPT and their antitumor activities", ACT PHAR SI, 22(9), 2001, pp. 827-830
84. Han, ZY; Wyche, JH; Sands, H; Pantazis, P
    9-nitrocamptothecin is an effective drug for the treatment of human lung tumors: Comparison of in vitro and in vivo studies
    ANTICANCER RESEARCH
    
    Z.Y. Han et al., "9-nitrocamptothecin is an effective drug for the treatment of human lung tumors: Comparison of in vitro and in vivo studies", ANTICANC R, 21(3B), 2001, pp. 1823-1827
85. Coleman, LW; Bronstein, IB; Holden, JA
    Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas
    ANTICANCER RESEARCH
    
    L.W. Coleman et al., "Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas", ANTICANC R, 21(2A), 2001, pp. 1167-1172
86. Smolewski, P; Bedner, E; Du, LT; Hsieh, TC; Wu, JM; Phelps, DJ; Darzynkiewicz, Z
    Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry
    CYTOMETRY
    
    P. Smolewski et al., "Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry", CYTOMETRY, 44(1), 2001, pp. 73-82
87. Sakuma, S; Lu, ZR; Kopeckova, P; Kopecek, J
    Biorecognizable HPMA copolymer-drug conjugates for colon-specific deliveryof 9-aminocamptothecin
    JOURNAL OF CONTROLLED RELEASE
    
    S. Sakuma et al., "Biorecognizable HPMA copolymer-drug conjugates for colon-specific deliveryof 9-aminocamptothecin", J CONTR REL, 75(3), 2001, pp. 365-379
88. Duncan, R; Gac-Breton, S; Keane, R; Musila, R; Sat, YN; Satchi, R; Searle, F
    Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic
    JOURNAL OF CONTROLLED RELEASE
    
    R. Duncan et al., "Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic", J CONTR REL, 74(1-3), 2001, pp. 135-146
89. Greenwald, RB
    PEG drugs: an overview
    JOURNAL OF CONTROLLED RELEASE
    
    R.B. Greenwald, "PEG drugs: an overview", J CONTR REL, 74(1-3), 2001, pp. 159-171
90. Bom, D; Curran, DP; Zhang, J; Zimmer, SG; Bevins, R; Kruszewski, S; Howe, JN; Bingcang, A; Latus, LJ; Burke, TG
    The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity
    JOURNAL OF CONTROLLED RELEASE
    
    D. Bom et al., "The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity", J CONTR REL, 74(1-3), 2001, pp. 325-333
91. Harada, M; Murata, J; Sakamura, Y; Sakakibara, H; Okuno, S; Suzuki, T
    Carrier and dose effects on the pharmacokinetics of T-0128, a camtothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats
    JOURNAL OF CONTROLLED RELEASE
    
    M. Harada et al., "Carrier and dose effects on the pharmacokinetics of T-0128, a camtothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats", J CONTR REL, 71(1), 2001, pp. 71-86
92. Vokes, EE; Gordon, GS; Rudin, CM; Mauer, AM; Watson, S; Krauss, S; Arrieta, R; Golomb, HM; Hoffman, PC
    A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer
    INVESTIGATIONAL NEW DRUGS
    
    E.E. Vokes et al., "A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer", INV NEW DR, 19(4), 2001, pp. 329-333
93. Turker, L
    A theoretical study on camptothecin-AM1 treatment
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    
    L. Turker, "A theoretical study on camptothecin-AM1 treatment", J MOL ST-TH, 549(3), 2001, pp. 275-283
94. Lu, CB; Fu, WM; Mattson, MP
    Telomerase protects developing neurons against DNA damage-induced cell death
    DEVELOPMENTAL BRAIN RESEARCH
    
    C.B. Lu et al., "Telomerase protects developing neurons against DNA damage-induced cell death", DEV BRAIN R, 131(1-2), 2001, pp. 167-171
95. Hung, CL; Doniger, J; Palini, A; Snyder, SW; Radonovich, MF; Brady, JN; Pantazis, P; Sadaie, MR
    9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: A potential alternative for HIV-Infection/AIDS therapy
    JOURNAL OF MEDICAL VIROLOGY
    
    C.L. Hung et al., "9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: A potential alternative for HIV-Infection/AIDS therapy", J MED VIROL, 64(3), 2001, pp. 238-244
96. Sai, K; Kaniwa, N; Ozawa, S; Sawada, JI
    A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4
    DRUG METABOLISM AND DISPOSITION
    
    K. Sai et al., "A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4", DRUG META D, 29(11), 2001, pp. 1505-1513
97. Bailly, C
    DNA relaxation and cleavage assays to study topoisomerase I inhibitors
    DRUG-NUCLEIC ACID INTERACTIONS
    
    C. Bailly, "DNA relaxation and cleavage assays to study topoisomerase I inhibitors", METH ENZYM, 340, 2001, pp. 610-623
98. Dumas, C; Royer, J; Husson, HP
    Partial synthesis of camptothecin analogs. Part 3: Easy approach to a quinoline-lactone system
    TETRAHEDRON LETTERS
    
    C. Dumas et al., "Partial synthesis of camptothecin analogs. Part 3: Easy approach to a quinoline-lactone system", TETRAHEDR L, 42(51), 2001, pp. 8973-8975
99. Ishibashi, H; Kato, I; Takeda, Y; Tamura, O
    Synthesis of a model compound of mappicine ketone based on sulfur-directed5-exo selective aryl radical cyclization onto enamides
    TETRAHEDRON LETTERS
    
    H. Ishibashi et al., "Synthesis of a model compound of mappicine ketone based on sulfur-directed5-exo selective aryl radical cyclization onto enamides", TETRAHEDR L, 42(5), 2001, pp. 931-933
100. Fulzele, DP; Satdive, RK; Pol, BB
     Growth and production of camptothecin by cell suspension cultures of Nothapodytes foetida
     PLANTA MEDICA
     
     D.P. Fulzele et al., "Growth and production of camptothecin by cell suspension cultures of Nothapodytes foetida", PLANTA MED, 67(2), 2001, pp. 150-152